US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,093.51

+25.731.24%

Number of Gainers:7

Number of Losers:3

Number of Flat:1

PE:- -

High:2,095.25

Open:2,066.22

Low:2,052.85

Close:2,067.79

Volume:21.05M

Turnover:1.03B

Market Cap:231.66B

Float Cap:230.94B

Loading ...

Aethlon Medical Fiscal Q1 2027 results: Lower expenses narrow the net loss

Aethlon Medical Inc: Q1 EPS of $-4.02

THOMSON REUTERS

Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program

THOMSON REUTERS

Quest Diagnostics Sets BRL 1.5-Per-Unit Distribution for Oct. 27 Payment

Inovio Publishes Q2 2026 Financial Results Presentation Focusing on INO-3107 BLA Review Progress

Inovio Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Press Release: Quest Diagnostics Declares Quarterly Cash Dividend

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

Inovio Q2 FY26 Net Loss Narrows to $6.01 Million; Operating Loss Improves to $18.62 Million

Inovio Pharmaceuticals Q2 EPS USD -0.07

THOMSON REUTERS

Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million

THOMSON REUTERS

Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek Files Initial Beneficial Ownership Statement

Aethlon Medical Inc Expected to Post a Loss of 78 Cents a Share - Earnings Preview

MacroGenics Rises on $10 Million Milestone Payment from Gilead

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis

MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development

THOMSON REUTERS

Global Drugmakers Invest Billions to Boost US Presence

Tango Falls After Wider-than-Expected Quarterly Loss

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/BK4583/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2093.5112,"timestamp":1787687999999,"preClose":2067.7861,"halted":0,"volume":21049515,"delay":0,"changeRate":0.012441,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":25.725098,"latestTime":"08-25 16:00:00 EDT","open":2066.2158,"high":2095.2493,"low":2052.853,"amount":1027272827.514876,"amplitude":0.020503,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.628967,"peRate":-75.212791,"turnoverRate":0.007796,"increases":7,"decrements":3,"flats":0,"marketCap":231657373876.625,"floatMarketCap":230942935095.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":2095.2493,"amplitude":0.020503,"preClose":2067.7861,"low":2052.853,"pbRate":"6.628967","latestPrice":2093.5112,"volume":21049515,"delay":0,"open":2066.2158,"prevYearClose":1682.3505,"prevWeekClose":2059.042,"prevMonthClose":1882.546,"prevQuarterClose":1802.0435,"fiveDayClose":2019.0911,"twentyDayClose":1934.8832,"sixtyDayClose":1882.2957,"secType":"PLATE","market":"US","turnoverRate":0.007796,"peRate":-75.212791,"marketCap":231657373876.625,"floatMarketCap":230942935095.625,"timestamp":1787687999999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":7,"down":3,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659039160","title":"Aethlon Medical Fiscal Q1 2027 results: Lower expenses narrow the net loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2659039160","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659039160?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:22","pubTimestamp":1786652525,"startTime":"0","endTime":"0","summary":"Aethlon Medical’s fiscal Q1 2027 results showed operating expenses falling 11.9% to $1.58 million, helping narrow the net loss to $1.55 million from $1.76 million. Basic and diluted loss per share improved to $4.02, though the weighted-average share count increased more than ninefold. Cash stood at $4.93 million on June 30, 2026, and a post-quarter public offering raised about $4.0 million in gross proceeds. Clinically, Aethlon dosed the first participant in the final cohort of its Australian Phase 1 Hemopurifier oncology study, while emphasizing that early biomarker observations remain preliminary.","market":"sg","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock8.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock8.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/earnings/262103672-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4583","AEMD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659193629","title":"Aethlon Medical Inc: Q1 EPS of $-4.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2659193629","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659193629?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","AEMD","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659162057","title":"Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2659162057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659162057?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA2D4XW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4583","AEMD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659697911","title":"Quest Diagnostics Sets BRL 1.5-Per-Unit Distribution for Oct. 27 Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2659697911","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659697911?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:40","pubTimestamp":1786642811,"startTime":"0","endTime":"0","summary":"Quest Diagnostics sets BRL 1.5-per-unit distribution for Oct. 27 paymentQuest Diagnostics declared a distribution of R$ 1.5 per unit for the fourth quarter of 2026.Shares trade with entitlement throug","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL4n5sxg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2506952170.USD","LU0950375773.USD","LU2506952097.USD","BK4583","BK4196","LU2506951958.HKD","LU2506951875.HKD","LU0823417653.USD","DGX","BK4588","LU1854104046.USD","LU0823417737.USD","LU1854103824.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659853721","title":"Inovio Publishes Q2 2026 Financial Results Presentation Focusing on INO-3107 BLA Review Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2659853721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659853721?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:40","pubTimestamp":1786570812,"startTime":"0","endTime":"0","summary":"Inovio publishes Q2 2026 financial results presentation focusing on INO-3107 BLA review progressInovio highlighted FDA review progress for INO-3107, citing a PDUFA target action date of Oct. 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLFFzM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188026","title":"Inovio Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188026","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188026?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:01","pubTimestamp":1786568512,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryInovio Pharmaceuticals IncINO.OQreported a quarterly adjusted loss of 7 cents per share for the quarter ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44926L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659890094","title":"Press Release: Quest Diagnostics Declares Quarterly Cash Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659890094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659890094?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"SECAUCUS, N.J., Aug. 12, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823417653.USD","LU2506952097.USD","BK4567","LU0823417737.USD","BK4583","LU2506951875.HKD","DGX","LU1854103824.USD","BK4196","BK4585","LU2506951958.HKD","LU1854104046.USD","BK4588","LU0950375773.USD","LU2506952170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900699","title":"Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900699","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565676,"startTime":"0","endTime":"0","summary":"Inovio Q2 net loss narrows on warrant gain, lower costsOverviewUS biotech firm's Q2 net loss narrowed yr/yr, driven by non-cash warrant gainQ2 operating expenses fell due to lower compensation and dev","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N449116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","GANX","TOVX","BK4139","BK4583","UNCY","BK4568","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907709","title":"Inovio Q2 FY26 Net Loss Narrows to $6.01 Million; Operating Loss Improves to $18.62 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907709","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907709?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:09","pubTimestamp":1786565377,"startTime":"0","endTime":"0","summary":"Inovio Q2 FY26 net loss narrows to $6.01 million; operating loss improves to $18.62 millionInovio posted a Q2 net loss of USD 6.01 million, narrowing from a USD 23.52 million loss a year earlier.R&D e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3dMTch:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","INO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907933","title":"Inovio Pharmaceuticals Q2 EPS USD -0.07","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907933?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX3FRP0B:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4568","INO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659090710","title":"Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659090710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659090710?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565102,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX3FRP0B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","INO","BK4583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906670","title":"Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906670","media":"Reuters","labels":["executive","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906670?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:24","pubTimestamp":1786548252,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions EVP, Chief Growth Officer Stephanie Duatschek files initial beneficial ownership statementEmergent BioSolutions EVP, chief growth officer Stephanie Duatschek reported 197,416 com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLCssPq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946938","title":"Aethlon Medical Inc Expected to Post a Loss of 78 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946938","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946938?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:23","pubTimestamp":1786483385,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc <AEMD.OQ> expected to post a loss of78cents a share - Earnings PreviewAethlon Medical IncAEMD.OQAEMD.Ois expected to  show no change in quarterly revenue when it reports  results o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44828G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","AEMD","BK4082","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946551","title":"MacroGenics Rises on $10 Million Milestone Payment from Gilead","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946551?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:17","pubTimestamp":1786483066,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics rises on $10 million milestone payment from Gilead** Shares of drug developer MacroGenicsMGNX.Orise 3.8% to $4.07 in extended trading** Company says it has received a $10 million mile","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4481HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","LU1585245621.USD","LU1934455863.HKD","LU0114720955.EUR","IBB","LU1066051498.USD","LU0109394709.USD","LU1066053197.SGD","SG9999015945.SGD","BK4550","LU0889565916.HKD","IE00B3T34201.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0823416689.USD","LU1430594728.SGD","LU2112291526.USD","LU2324357040.USD","TMED","GILD","LU0882574055.USD","BMED","LU0234570918.USD","LU1037948541.HKD","LU1037948897.HKD","LU1674673691.USD","LU1934455194.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU1057294990.SGD","MGNX","BK4585","IBBQ","BBH","LU1839511570.USD","LU2089984988.USD","LU2087621335.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015952.SGD","LU1571399168.USD","IE00BSNM7G36.USD","TBXU","MEDI","BIB","LU1023059063.AUD","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658494587","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2658494587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658494587?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:36","pubTimestamp":1786480560,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 2.04% to $135.77 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.32% to 7,728.20 and Dow Jones Industrial Average  falling 0.34% to 53,791.85.Gilead Sciences Inc. closed 13.68% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 0.77% to $259.80, Pfizer Inc.  fell 1.59% to $26.62, and Abbott Laboratories  rose 1.01% to $109.72.Trading volume  remained 2.9 million below its 50-day average volume of 8.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 11, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","BK4139","LU1585245621.USD","LU0122379950.USD","LU1061106388.HKD","LU1934455863.HKD","IE00BKVL7J92.USD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU0109394709.USD","LU1066051498.USD","LU1066053197.SGD","SG9999015945.SGD","BK4550","LU0889565916.HKD","BK4578","IE00B3T34201.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0823416689.USD","LU0861579265.USD","IE0002270589.USD","LU1430594728.SGD","LU2112291526.USD","LU2324357040.USD","TMED","GILD","BIB","LU0882574055.USD","SG9999015978.USD","BMED","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1037948897.HKD","LU1674673691.USD","LU1934455194.USD","SG9999015986.USD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU1057294990.SGD","BK4585","IBBQ","BBH","LU1839511570.USD","LU2089984988.USD","LU2087621335.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015952.SGD","BK4532","LU1571399168.USD","IE00BSNM7G36.USD","TBXU","MEDI","BK4568","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658594383","title":"MacroGenics Raih Pembayaran USD 10 Juta Usai Gilead Ambil Lisensi Program Bispesifik Praklinis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658594383","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658594383?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:11","pubTimestamp":1786479087,"startTime":"0","endTime":"0","summary":"MacroGenics raih pembayaran USD 10 juta usai Gilead ambil lisensi program bispesifik praklinisMacroGenics mengantongi pembayaran USD 10 juta usai Gilead mengeksekusi opsi lisensi eksklusif program bis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL6BF7yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SG9999014005.SGD","LU2468319806.SGD","GILD","LU0320765992.SGD","IE00BKVL7J92.USD","BK4566","IE00BKPKM429.USD","IE00BGHQF748.EUR","IBBQ","LU1066051498.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","NDAQ","TBXU","LU0122379950.USD","IE00BN0W2V16.EUR","LU1061106388.HKD","IE0002270589.USD","LU0889565916.HKD","TMED","LU2210150020.SGD","SG9999015978.USD","MEDI","LU2089984988.USD","IE00B19Z3B42.SGD","BK4139","BIB","LU0965509283.SGD","IE00BN0W2T93.GBP","LU0861579265.USD","LU0314104364.USD","IE00B3T34201.USD","LU1934455863.HKD","BK4583","BK4532","BBH","MGNX","BK4588","IBB","LU0058720904.USD","LU0882574055.USD","BK4568","LU1934455277.USD","LU1934455194.USD","LU2112291526.USD","SG9999014021.USD","BMED","LU0965509010.AUD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658948444","title":"MacroGenics - Remains Eligible to Receive up to Approximately $1.6 Bln in Additional Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658948444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658948444?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478768,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4481HI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","LU0965509101.SGD","LU1571399168.USD","SG9999015978.USD","LU1430594728.SGD","IE00B3T34201.USD","LU2112291526.USD","SG9999015952.SGD","BK4568","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1674673691.USD","BIB","IBBQ","SG9999015986.USD","BBH","LU2468319806.SGD","LU0882574055.USD","LU1934455863.HKD","BK4566","LU1839511570.USD","LU1037948541.HKD","LU0058720904.USD","BK4532","LU1585245621.USD","LU0965509283.SGD","LU1778281490.HKD","LU0109394709.USD","LU1934455277.USD","SG9999015945.SGD","IE00B19Z3581.USD","LU1023059063.AUD","BK4550","MGNX","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","LU0889565916.HKD","BK4578","TBXU","LU1066051498.USD","LU1674673428.USD","LU0234570918.USD","BK4585","IBB","BMED","LU0965509010.AUD","TMED","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0320765489.SGD","LU1196500208.SGD","LU0124676726.USD","LU1066051811.HKD","IE00BFSS7M15.SGD","LU1035775433.USD","LU1670711040.USD","LU2264538146.SGD","LU2125909247.SGD","LU0889565916.HKD","LU0096364046.USD","LU1989772923.USD","SG9999015945.SGD","LU0130517989.USD","LU0130102774.USD","SG9999014575.USD","LU0158827781.USD","LU0640476718.USD","LU0726765562.USD","LU2471134879.HKD","LU2237443382.USD","LU0234572021.USD","BK4550","IE00B42XCP33.USD","SG9999001440.SGD","LU0203201768.USD","VHT","LU1093756325.SGD","LU0672654240.SGD","LU1989771016.USD","XLV","LU1116320901.HKD","IE00BDGV0183.EUR","ELIS","LU2111349929.HKD","BK7067","LU2357305700.SGD","IE0009355771.USD","TBXU","LU1934455194.USD","LU2462591350.SGD","SG9999011175.SGD","LU2361044865.SGD","IE00BBT3K403.USD","LU0162691827.USD","LU1814569148.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU0859254822.USD","CANC","LU0395794307.EUR","LU1548497426.USD","PPH","LU1201861249.SGD","LU0203347892.USD","LU2456880835.USD","LU0345769128.USD","LU0306807586.USD","MHIP","NVO","BK4592","PAWZ","LU1868836757.USD","LU2028103732.USD","IE000MB6IJN5.SGD","LU1670628061.USD","LU0661504455.SGD","LU0456855351.SGD","IE000BZT7R73.USD","IE0002141913.USD","LU1221951129.SGD","LU0098860793.USD","LU0057025933.USD","IE00B19Z9P08.USD","LU0426417589.USD","LU0310799852.SGD","LU0787776722.HKD","LU2237443978.SGD","LU0321505868.SGD","BK4581","IE0005OL40V9.USD","BK4534","LLYX","LU2491050071.SGD","IE00BN8TJ469.HKD","LU1935042991.SGD","LU0234570918.USD","LU0472753341.HKD","IE00B3PB1722.GBP","LU0198837287.USD","LU1221951046.USD","LU1506573853.SGD","LU1868837136.USD","LU1778281490.HKD","BK4559","LU0029864427.USD","LU1674673691.USD","LU1496350171.SGD","LU1035773651.USD","IE00BSNM7G36.USD","LU2087621335.USD","LU0211327993.USD","LU0266013472.USD","LU2063271972.USD","LU1267930573.SGD","IE000SO60NU8.SGD","LU0053666078.USD","LU2433249047.HKD","BK7508","LU0545562505.USD","LU0466842654.USD","LU0203345920.USD","LU1232071149.USD","LU0203202063.USD","LU1670710661.SGD","IE00BFXG1179.USD","SNY","SGXZ57979304.SGD","LU2129689605.HKD","LU2347655156.SGD","LU0708994859.HKD","LU2403377893.USD","SG9999014567.USD","LU1868836591.USD","IE00B4R5TH58.HKD","SG9999003800.SGD","LU0006306889.USD","LU0058720904.USD","LU0353189763.USD","AMGN","IE00B4JS1V06.HKD","LU0985481810.HKD","LU2237443549.SGD","IXJ","LU0069063385.USD","IHE","LU2133065610.SGD","LU1267930813.SGD","HRTS","LU1093756168.USD","LU0820561909.HKD","LU0980610538.SGD","IE00B19Z3581.USD","LU0225283273.USD","LU2360032135.SGD","LU0861579265.USD","SG9999002232.USD","IE00BJJMRY28.SGD","LU0316494557.USD","LU2361044949.HKD","LU2471134796.USD","SG9999017495.SGD","LU0477156953.USD","LU0122379950.USD","LU1037948541.HKD","PBE","LU2168564065.EUR","LU2242652126.USD","LU0323591593.USD","ILDR","LU2106854487.HKD","GSKH","LU0210536198.USD","IE00BGHQF631.EUR","LU2430703178.SGD","LU1804176565.USD","LU0256863902.USD","LLYZ","IE0004445239.USD","LU0471298694.HKD","SGXZ51526630.SGD","LU0882574139.USD","SG9999015341.SGD","LU0225771236.USD","LU0786609619.USD","LU0882574055.USD","IE00B1BXHZ80.USD","LU2487616109.SGD","LU0471298777.SGD","SG9999002224.SGD","IE00BJLML261.HKD","03165","LU0094547139.USD","LU1066051498.USD","LU0417517546.SGD","LU0174119429.USD","LU1032466523.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU1732799900.SGD","LU1430594728.SGD","LU2211815571.USD","LU2746668974.SGD","LU0265550359.USD","LU2168564495.EUR","LU2750360641.GBP","IBBQ","LU1670710588.SGD","BK4599","LU2357627491.SGD","IE00BKVL7J92.USD","LU1894683264.USD","LU2168563687.JPY","PFE","LLII","LU2168564222.USD","IE00BLSP4452.SGD","LU1929549753.HKD","LU2237443622.USD","LU0354030511.USD","SG9999018865.SGD","LU1629891620.HKD","LU0943347566.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1720051108.HKD","LU1066053197.SGD","LU1074936037.SGD","LU0211328371.USD","LU1291159041.SGD","LU1989772840.SGD","LU2023250504.SGD","LU2242646821.SGD","SG9999001176.SGD","LU1069347547.HKD","AZN","LU1061106388.HKD","LU1244550221.USD","TMED","BK4516","BIB","LU2756315318.SGD","LU0823434740.USD","LU0320765646.SGD","LU2023250843.SGD","SG9999015358.SGD","RHHBY","SG9999014906.USD","JNJ","SG9999018857.SGD","LU0345770308.USD","LU0683600562.USD","LU0097036916.USD","LU0354030438.USD","LU1670711123.USD","BK4139","IE00BN29S564.USD","IE00BVYPNW00.USD","LU1366192091.USD","LU2462157665.USD","LU0079474960.USD","BK4583","BK4504","MRK","IE00BFTCPJ56.SGD","LU2089984988.USD","IE00BJT1NW94.SGD","LU2112291526.USD","LU0072461881.USD","AGNG","LU1043141396.HKD","LU1829250122.USD","LU2237443895.HKD","RXL","LU1699723380.USD","LU0965509010.AUD","LU1712237335.SGD","LU2471134952.CNY","LU2602419157.SGD","LU1069344957.HKD","LU0210528500.USD","PJP","LU0994945656.USD","SGXZ99366536.SGD","LU0225284248.USD","LU0267386448.USD","LU2125154778.USD","LU1057294990.SGD","IE00B894F039.SGD","LU0868494617.USD","LU0648001328.SGD","IE00BK4W5M84.HKD","IBB","GLAM","IE0034235303.USD","LU0823434583.USD","LU0985320562.USD","JDOC","LU0133085943.USD","NVOX","LU0061475181.USD","LU2756315664.SGD","SG9999015986.USD","LU1244550577.SGD","LU2129689514.USD","LU1032955483.USD","BMY","LU2461242641.AUD","OZEM","LU1127390331.HKD","LU1551013425.SGD","LU0820562030.AUD","IE00BK4W5L77.USD","LU2750360997.AUD","LU1623119135.USD","LU2087625088.SGD","IE0000B7K699.USD","LU1983299246.USD","LU0211331839.USD","BMED","LU1571399168.USD","NVOH","LU1868837300.USD","LU0385154629.USD","SG9999014542.SGD","SG9999001176.USD","LU0289739343.SGD","LU0689472784.USD","LU2125154935.USD","LU1868836914.USD","LU0158827948.USD","LU2596442595.SGD","LU1003077747.HKD","LU0128525929.USD","LU1914381329.SGD","LU0823416689.USD","LU1267930730.SGD","IE00B19Z9Z06.USD","LU0426412945.USD","LU2347655073.USD","LU0553294199.USD","LU2125909593.SGD","LU2896262040.SGD","LU1145028129.USD","LU0511384066.AUD","LU1720051017.SGD","LU2417539215.USD","LU1064131342.USD","LU0106261372.USD","LLY","LU1670627923.USD","LU0820561818.USD","IE00B1XK9C88.USD","LU0965509101.SGD","LU0432979614.USD","BK4578","LU2468319806.SGD","LU0795875169.SGD","LU2592432038.USD","LU2271345857.HKD","LU0109391861.USD","LU2213496289.HKD","LU0320765059.SGD","LU1267930490.SGD","IE0002270589.USD","LU2236285917.USD","ABBV","LU2023250330.USD","LU0109394709.USD","LU0889566641.SGD","FTXH","LU1228905540.USD","LU1674673428.USD","LU2168564149.EUR","MEDI","LU2505996681.GBP","LU0792757196.USD","IE00BKDWB100.SGD","LU2237438978.USD","MEDX","LU0689626769.HKD","LU1037948897.HKD","LU2089284900.SGD","BIIB","LU2265009873.SGD","LU1116320737.USD","SG9999014914.USD","LU2324357040.USD","LU1323610961.USD","BK4533","LU1732800096.USD","LU1228905037.USD","LU0912757837.SGD","LU0310800379.SGD","LU0738911758.USD","BBH","LU0070302665.USD","LU1979441026.SGD","LU1988902786.USD","IE00B19Z3B42.SGD","LU1066051225.USD","BK4585","LU0170899867.USD","LU2552382132.HKD","LU2361045086.USD","LU2552382215.SGD","SGXZ31699556.SGD","LU0320765992.SGD","LU2023251221.USD","IE0001KFT4U8.USD","LU1551013342.USD","04332","LU0289961442.SGD","LU2746668461.USD","LU0345769631.USD","NVS","SG9999015978.USD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","LU1934455863.HKD","SG9999015952.SGD","BK7501","LU1244550494.USD","LU2491050154.USD","LU0154236417.USD","LU2108987350.USD","GILD","AZNH","LU1923622614.USD","LU0070217475.USD","BK4568","IE000F7OJYX1.SGD","WDNA","IE00BJJMRZ35.SGD","LU1883839398.USD","BK7511","SG9999014880.SGD","GSK","LU0306806265.USD","ELIL","LU0208291251.USD","IE000WAW04H5.SGD","TRUH","BK4588","LU1974910355.USD","LU1894683348.USD","LU0321505439.SGD","LU0964807845.USD","CSL.AU","LU0795875086.SGD","LU0256863811.USD","LU2505996509.AUD","BK4566","SG9999014559.SGD","LU0965508806.USD","LU0965509283.SGD","LU1023059063.AUD","LU1496350502.SGD","LU2471134523.USD","IE00B7SZLL34.SGD","IYH","LU2430703251.USD","LU0942090050.USD","LU2360106947.USD","IE00B775H168.HKD","SG9999013999.USD","CURE","LU0708995401.HKD","SG9999014898.SGD","LU0949170772.SGD","LU0114720955.EUR","IE00BZ1G4Q59.USD","LU0545039389.USD","LU1839511570.USD","LU1280957306.USD","IE0004445015.USD","LU1941712348.USD","LU2430703095.HKD","LU0237698245.USD","LU2237443465.HKD","LU0353189680.USD","LU1585245621.USD","LU1917777945.USD","IE00BKPKM429.USD","LU1941712264.USD","BK4007","LU0345770993.USD","IE00B7KXQ091.USD","SGXZ80539844.SGD","IE00B2B36J28.USD","LU1261432733.SGD","IE00BVYPNV92.GBP","GSK.UK","LU0868494708.USD","GDOC","LU1718418525.SGD","LU1059921491.USD","LU2552382058.USD","THNR","BK4532","LU1043141123.HKD","LU1121112475.USD","LU0238689110.USD","LU1934455277.USD","FHLC","LU2089283258.USD","LU1162221912.USD","IE00BFSS8Q28.SGD","SGXZ81514606.USD","LU0265550946.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658115349","title":"Tango Falls After Wider-than-Expected Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658115349","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658115349?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:18","pubTimestamp":1786461505,"startTime":"0","endTime":"0","summary":"BUZZ-Tango falls after wider-than-expected quarterly loss** Shares of drug developer Tango TherapeuticsTNGX.Ofall 3.3% to $26.75** Co reportsQ2 lossof 37 cents/share, vs. analysts' average loss estima","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44814E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","BBH","MEDI","IBBQ","IDNA","LU0320765992.SGD","PTH","LU1674673428.USD","LU1778281490.HKD","TBXU","IE00B7SZLL34.SGD","BMED","IE00BJJMRZ35.SGD","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","BIB","IE0002270589.USD","TNGX","LU0234570918.USD","IE00B2B36J28.USD","LU2087621335.USD","RVMD","LU0861579265.USD","IE0009355771.USD","BK4588","IE00B4R5TH58.HKD","SG9999015952.SGD","BK4585","LU0965509010.AUD","LU0965508806.USD","LU1934455863.HKD","LU2089984988.USD","BK4583","LU0289739699.SGD","LU1674673691.USD","IE00BJT1NW94.SGD","BK4532","LU1066051498.USD","CANC","GILD","LU1934455277.USD","LU0114720955.EUR","IBB","BK4139","LU2324357040.USD","IE00B19Z3581.USD","LU0109394709.USD","TMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}